Literature DB >> 1119827

Familial progressive systemic scleroderma.

R E Greger, R E Greger.   

Abstract

Three patients seen with similar findings of progressive systemic scleroderma. Two of the patients, a father and son, had very similar skin changes, sclerodactyly, Raynaud phenomenon, gastrointestinal involvement, and pulmonary symptoms. The three patients were from the highly inbred Brandywine triracial isolate. This isolate is a group of families who have been inbreeding since 1660 and now have the highest gene frequencies for sickle cell anemia and oculocutaneous albinism in the United States. There have been only a few reported cases of familial scleroderma and the hereditary aspect of the disease has not been well established. This report shows that the mortality for scleroderma in this isolate is at least 250 times the mortality of the general population, thus suggesting a probable genetic predisposition for the disease.

Entities:  

Mesh:

Year:  1975        PMID: 1119827

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

Review 1.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.

Authors:  P J Maddison; R P Skinner; R S Pereira; C M Black; B M Ansell; M I Jayson; N R Rowell; K I Welsh
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

3.  Animal model of human disease. Avian scleroderma. An inherited fibrotic disease of white Leghorn chickens resembling progressive systemic sclerosis.

Authors:  J van de Water; M E Gershwin
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

4.  Genetic control of avian scleroderma.

Authors:  H Abplanalp; M E Gershwin; E Johnston; J Reid
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families.

Authors:  Chang-Fu Kuo; Shue-Fen Luo; Kuang-Hui Yu; Lai-Chu See; Weiya Zhang; Michael Doherty
Journal:  Arthritis Res Ther       Date:  2016-10-12       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.